Physician

Michael Julius Dibernardo, MD

According to 2025 Medicare claims, Michael Dibernardo, MD (NPI: 1235109851) practices family practice in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Clay, MO. This provider's primary affiliated billing organization is MERITAS HEALTH CORPORATION (NPI: 1619606159; TIN: 43-1639806) and primary practice location at 64155-2262. Dibernardo is affiliated with the Centrus Health LLC (ACO ID: A5304), participating under the MSSP model.

Dibernardo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 680 traditional Medicare patients, billed 44,387 HCPCS/CPT codes, and received $745,843 in Medicare payments. The top billing code was 80061 (Blood test, lipids (cholesterol and triglycerides)). Part D data shows 16,572 prescription claims across 789 beneficiaries totaling $1,388,321 in drug costs, led by Ozempic (Semaglutide). DME data shows 519 claims. Open Payments data shows 15 records totaling $342. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $172,435 to $745,843. Similarly, Part D prescription costs have moved sharply higher in recent years, from $481,935 to $1,388,321. In contrast, DME billing represents a smaller volume and rose steadily, from $12,423 to $30,590.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	402	11,711	$172,435
2016	415	5,973	$151,664
2017	437	5,943	$161,613
2018	497	7,860	$160,395
2019	502	8,965	$158,578
2020	417	6,576	$122,924
2021	487	7,255	$175,222
2022	433	6,938	$143,478
2023	441	6,990	$159,442
2024	680	44,387	$745,843

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	405	9,205	$481,935
2016	427	9,062	$446,195
2017	488	10,235	$457,710
2018	580	11,364	$563,809
2019	606	11,465	$620,372
2020	580	12,250	$696,503
2021	621	12,298	$736,825
2022	728	13,225	$908,579
2023	773	14,190	$1,116,544
2024	789	16,572	$1,388,321

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	88	295	$8,848
2016	105	407	$14,363
2017	71	331	$11,964
2018	59	325	$9,056
2019	57	333	$9,031
2020	67	382	$12,317
2021	97	478	$17,114
2022	118	432	$14,024
2023	67	453	$19,845
2024	98	519	$30,184

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80061	Blood test, lipids (cholesterol and triglycerides)	304	348	$13
80053	Blood test, comprehensive group of blood chemicals	340	466	$10
96372	Injection of drug or substance under skin or into muscle	306	543	$10
36415	Insertion of needle into vein for collection of blood sample	545	938	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	320	462	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	250	9,232	$287,937
Jardiance	Empagliflozin	197	8,624	$166,125
Eliquis	Apixaban	124	5,998	$113,796
Mounjaro	Tirzepatide	79	2,468	$90,469
Trulicity	Dulaglutide	53	1,652	$55,705

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	25	$10,097
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	54	$3,871
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	15	40	$2,114
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	58	$1,880
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	21	$1,611

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$342	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Julius Dibernardo, MD?

Tedicare shows public-source Medicare data for Michael Julius Dibernardo, MD (NPI 1235109851), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Julius Dibernardo, MD have ACO affiliation data?

Michael Julius Dibernardo, MD is shown with ACO affiliation data for Centrus Health LLC (MSSP, ACO ID A5304).

What billing organization is linked to Michael Julius Dibernardo, MD?

Michael Julius Dibernardo, MD is linked to MERITAS HEALTH CORPORATION (billing NPI 1619606159) in the available physician profile data.

Does Michael Julius Dibernardo, MD have Open Payments data?

Michael Julius Dibernardo, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.